BioSight
Companies
CATALYST PHARMACEUTICALS, INC. logo

CPRX

NASDAQCORAL GABLES, FL
CATALYST PHARMACEUTICALS, INC.

Catalyst Pharmaceuticals markets three approved drug products: FIRDAPSE and AGAMREE (which appear to be newer focus areas), along with FYCOMPA. The firm operates as a commercial-stage biotech company focused on selling these marketed drugs while managing patent litigation and maintaining regulatory compliance. Current priorities include generating profitable, cash-flow positive operations from existing product sales rather than advancing drugs through clinical development.

Price history not yet available for CPRX.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar